Spanish Agency of Medicines and Medical Devices
GPTKB entity
Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:government_agency
|
| gptkbp:country |
gptkb:Spain
|
| gptkbp:director |
María Jesús Lamas
|
| gptkbp:established |
gptkb:2011
|
| gptkbp:function |
gptkb:information_dissemination
gptkb:guidelines gptkb:regulations data collection environmental impact assessments regulatory compliance community outreach policy development research funding risk assessment stakeholder engagement sustainability initiatives public consultations safety monitoring stakeholder collaboration training and education data privacy compliance adverse event reporting healthcare quality improvement product recalls market surveillance consumer information public health protection patient safety initiatives pharmacovigilance regulatory harmonization scientific advice transparency initiatives health technology assessment digital health initiatives healthcare access initiatives regulatory framework development collaboration with international organizations support for health professionals drug pricing policy monitoring of drug safety guidelines development authorization of clinical trials evaluation of medicines inspections of manufacturing sites ethical standards enforcement collaboration with European Medicines Agency promotion of research and innovation |
| gptkbp:headquarters |
gptkb:Madrid
|
| https://www.w3.org/2000/01/rdf-schema#label |
Spanish Agency of Medicines and Medical Devices
|
| gptkbp:parent_organization |
gptkb:Ministry_of_Health,_Spain
|
| gptkbp:responsible_for |
gptkb:medical_devices
regulation of medicines |
| gptkbp:website |
www.aemps.gob.es
|
| gptkbp:bfsParent |
gptkb:Spanish_National_Health_System
|
| gptkbp:bfsLayer |
7
|